Occurrence of Colorectal Cancer After a Negative Colonoscopy in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis
Open Access
- 28 February 2024
- journal article
- review article
- Published by International Institute of Anticancer Research in In Vivo
- Vol. 38 (2) , 523-530
Abstract
Background/Aim: Despite the application of colorectal cancer (CRC) surveillance guidelines, the detection of early neoplastic lesions might be difficult in patients with inflammatory bowel disease (IBD). To explore the risk of post-colonoscopy CRC (PCCRC) in patients with IBD we performed a systematic review and meta-analysis. Patients and Methods: A systematic literature search was performed (PROSPERO; no. CRD42023453049). We included studies reporting the 3-year PCCRC (PCCRC-3y) prevalence, according to World Endoscopy Organization (WEO)-endorsed definition, in IBD and non-IBD patients. As primary outcome we evaluated the PCCRC-3y prevalence, according to WEO definitions, in IBD- and non-IBD patients and calculated the odds ratio (OR). The secondary outcome was to assess risk factors for PCCRC development in IBD patients. Results: Three retrospective observational cohort studies were included. The pooled PCCRC-3y rate in patients with IBD was 30.8% [95% confidence interval (CI)=24.4-37.5%] and in non-IBD patients was 6.8% (95%CI=6.2-7.4%). The PCCRC-3y occurrence in IBD patients was significantly higher than that in non-IBD patients (OR=6.04; 95%CI=4.04-9.4; I2=95%), but a high heterogeneity among studies was noted. Furthermore, patients with ulcerative colitis (UC) had a significantly higher prevalence of PCCRC than patients with Crohn’s Disease (CD): 30.9% (95%CI=27.8-34.2%) vs. 22.3% (95%CI=18-27%), respectively (OR=1.6, 95%CI=1.2-2.2; I2=0%). Conclusion: One-third of CRC in IBD patients were PCCRC, and these numbers were significantly higher when compared with those in non-IBD patients. Furthermore, the prevalence of PCCRC in patients with UC was higher compared to those with CD. However, prospective studies are required to better characterize risk factors for PCCRC development in patients with IBD.Keywords
This publication has 28 references indexed in Scilit:
- Characteristics and Survival of Patients With Inflammatory Bowel Disease and Postcolonoscopy Colorectal CancersClinical Gastroenterology and Hepatology, 2022
- Postcolonoscopy Colorectal Cancer in Sweden From 2003 to 2012: Survival, Tumor Characteristics, and Risk FactorsClinical Gastroenterology and Hepatology, 2020
- Interval Colorectal Cancer in Inflammatory Bowel Disease: The Role of Guideline AdherenceDigestive Diseases and Sciences, 2019
- Incidence of Interval Colorectal Cancer Among Inflammatory Bowel Disease Patients Undergoing Regular Colonoscopic SurveillanceClinical Gastroenterology and Hepatology, 2015
- SCENIC International Consensus Statement on Surveillance and Management of Dysplasia in Inflammatory Bowel DiseaseGastroenterology, 2015
- Improving quality of care in inflammatory bowel disease: What changes can be made today?Journal of Crohn's and Colitis, 2014
- Cancer Risk in Inflammatory Bowel Disease According to Patient Phenotype and Treatment: A Danish Population-Based Cohort StudyAmerican Journal of Gastroenterology, 2013
- Rates of New or Missed Colorectal Cancers After Colonoscopy and Their Risk Factors: A Population-Based AnalysisGastroenterology, 2007
- Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel diseaseAlimentary Pharmacology & Therapeutics, 2003
- Colonoscopic miss rates of adenomas determined by back-to-back colonoscopiesGastroenterology, 1997